X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (120) 120
immunology (80) 80
peptides (78) 78
chemistry (69) 69
metallurgy (69) 69
organic chemistry (69) 69
human necessities (64) 64
hygiene (64) 64
medical or veterinary science (64) 64
preparations for medical, dental, or toilet purposes (64) 64
antigens, neoplasm - immunology (54) 54
biochemistry (47) 47
beer (46) 46
enzymology (46) 46
microbiology (46) 46
mutation or genetic engineering (46) 46
spirits (46) 46
vinegar (46) 46
wine (46) 46
t-lymphocytes, cytotoxic - immunology (45) 45
neoplasm proteins - immunology (44) 44
compositions thereof (43) 43
culture media (43) 43
melanoma - immunology (43) 43
microorganisms or enzymes (43) 43
propagating, preserving or maintaining microorganisms (43) 43
oncology (39) 39
amino acid sequence (37) 37
peptide fragments - immunology (34) 34
melanoma (33) 33
cd8-positive t-lymphocytes - immunology (32) 32
mart-1 antigen (31) 31
lymphocytes (30) 30
index medicus (29) 29
molecular sequence data (29) 29
t cells (28) 28
animals (27) 27
cancer (26) 26
epitopes (24) 24
epitopes, t-lymphocyte - immunology (24) 24
expression (24) 24
immunotherapy (24) 24
mice (23) 23
cd4-positive t-lymphocytes - immunology (22) 22
tumor cells, cultured (22) 22
antigens, neoplasm - metabolism (21) 21
cancer vaccines - immunology (21) 21
hla-a2 antigen - immunology (21) 21
immune-response (20) 20
female (19) 19
tumor immunity (19) 19
in-vitro (18) 18
adult (17) 17
antigens, neoplasm - genetics (17) 17
ctl (17) 17
identification (17) 17
investigating or analysing materials by determining theirchemical or physical properties (17) 17
measuring (17) 17
melanoma patients (17) 17
membrane proteins - immunology (17) 17
physics (17) 17
testing (17) 17
antigens (16) 16
clone cells (16) 16
medicine, research & experimental (16) 16
cd8-positive t-lymphocytes - metabolism (15) 15
cells, cultured (15) 15
t-lymphocytes, regulatory - immunology (15) 15
tumors (15) 15
flow cytometry (14) 14
immune-responses (14) 14
compositions or test papers therefor (13) 13
condition-responsive control in microbiological orenzymological processes (13) 13
human (13) 13
lymphocyte activation (13) 13
lymphocytes, tumor-infiltrating - immunology (13) 13
measuring or testing processes involving enzymes, nucleicacids or microorganisms (13) 13
memory (13) 13
middle aged (13) 13
neoplasm proteins - metabolism (13) 13
peptides - immunology (13) 13
processes of preparing such compositions (13) 13
aged (12) 12
antigens, neoplasm (12) 12
cell line (12) 12
cells (12) 12
dendritic cells (12) 12
immune response (12) 12
male (12) 12
neoplasm proteins - genetics (12) 12
neoplasms - immunology (12) 12
recognition (12) 12
t lymphocytes (12) 12
antigen (11) 11
epitopes, t-lymphocyte - metabolism (11) 11
genes (11) 11
metastatic melanoma (11) 11
peptide (11) 11
reactive ctl (11) 11
t-lymphocyte subsets - immunology (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences, ISSN 0027-8424, 05/2009, Volume 106, Issue 21, pp. 8635 - 8640
Recent studies have suggested a close relationship between CD4 + FOXP3 + regulatory T cells (Tregs) and proinflammatory IL-17-producing T helper cells (T H 17)... 
Biological Sciences
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2010, Volume 107, Issue 45, pp. 19402 - 19407
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 7, p. e0160538
[This corrects the article DOI: 10.1371/journal.pone.0150623.]. 
Antigens | Whites | Immune response | Lung cancer | Cancer
Journal Article
Journal Article
Clinical Immunology, ISSN 1521-6616, 05/2009, Volume 131, Issue 2, pp. 298 - 307
Natural CD4 CD25 regulatory T cells (Treg) and interleukin 17 (IL-17)-producing T helper cells (T 17) carry out opposite functions, the former maintaining... 
IL-1β | IL-2 | Treg
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2016, Volume 11, Issue 3, p. e0150623
Immunotherapy approaches using checkpoint blockade, alone, or in combination with tumor antigen vaccination, or adoptive cell transfer, are emerging as... 
NY-ESO-1 | EWINGS-SARCOMA | THERAPY | CD4 T-CELLS | GENE | MULTIDISCIPLINARY SCIENCES | ANTIBODY | MUTATIONS | IDENTIFICATION | EXPRESSION | FEATURES | Adenocarcinoma - pathology | CD8-Positive T-Lymphocytes - pathology | Humans | Molecular Sequence Data | Lung Neoplasms - pathology | CD4-Positive T-Lymphocytes - pathology | Antigens, Neoplasm - chemistry | Case-Control Studies | Peptides - administration & dosage | Antigens, Neoplasm - administration & dosage | CD4-Positive T-Lymphocytes - immunology | Epitopes - immunology | Immunotherapy, Active - methods | Carcinoma, Non-Small-Cell Lung - pathology | Amino Acid Sequence | Antigens, Neoplasm - genetics | Gene Expression | Peptides - chemistry | Antigens, Neoplasm - immunology | Adenocarcinoma - immunology | Cancer Vaccines - administration & dosage | Cancer Vaccines - biosynthesis | Peptides - immunology | Lung Neoplasms - therapy | Interferon-gamma - agonists | Carcinoma, Non-Small-Cell Lung - immunology | Cancer Vaccines - immunology | Carcinoma, Non-Small-Cell Lung - therapy | Lung Neoplasms - immunology | Adenocarcinoma - therapy | CD8-Positive T-Lymphocytes - drug effects | Epitopes - chemistry | Primary Cell Culture | CD8-Positive T-Lymphocytes - immunology | CD4-Positive T-Lymphocytes - drug effects | Interferon-gamma - biosynthesis | Cancer vaccines | Antigens | Care and treatment | Immune response | Peptides | Immunotherapy | Lung cancer, Small cell | Lung cancer, Non-small cell | T cells | Adenocarcinoma | Genes | Lung cancer | Vaccination | Lymphocytes T | Identification | Vaccines | Metastasis | Cancer therapies | Proteins | Review boards | Melanoma | Non-small cell lung carcinoma | Epitopes | Patients | CD4 antigen | Chemotherapy | Immune checkpoint | Immunogenicity | Mutation | Tumors | Cancer
Journal Article
European Journal of Immunology, ISSN 0014-2980, 02/2015, Volume 45, Issue 2, pp. 474 - 479
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2007, Volume 104, Issue 21, pp. 8947 - 8952
The use of recombinant tumor antigen proteins is a realistic approach for the development of generic cancer vaccines, but the potential of this type of... 
T lymphocytes | Cancer vaccines | Antigens | Cross priming | B lymphocytes | Plasmids | Vaccination | Melanoma | Antibodies | Tumors | Cancer vaccine | PLASMACYTOID DENDRITIC CELLS | B-CELLS | IMMUNIZATION | CANCER-PATIENTS | EPITOPE | cancer vaccine | CANCER/TESTIS ANTIGENS | IMMUNE-RESPONSES | DNA | MULTIDISCIPLINARY SCIENCES | IDENTIFICATION | TUMOR-ANTIGEN | Recombinant Proteins - therapeutic use | Mannitol - blood | Humans | Membrane Proteins - adverse effects | Epitopes, B-Lymphocyte - immunology | Membrane Proteins - therapeutic use | Recombinant Proteins - adverse effects | Th1 Cells - immunology | Oleic Acids - blood | Oligodeoxyribonucleotides - blood | Antigens, Neoplasm - therapeutic use | Antigens, Neoplasm - blood | Antibodies - immunology | Oligodeoxyribonucleotides - adverse effects | Antigens, Neoplasm - adverse effects | Oleic Acids - adverse effects | Membrane Proteins - blood | Oligodeoxyribonucleotides - therapeutic use | Mannitol - adverse effects | Oligodeoxyribonucleotides - immunology | Antigens, Neoplasm - immunology | Oleic Acids - therapeutic use | Mannitol - therapeutic use | Membrane Proteins - immunology | Immunotherapy - adverse effects | Mannitol - analogs & derivatives | Neoplasms - drug therapy | Recombinant Proteins - blood | Cancer Vaccines - immunology | Cross-Priming - immunology | Recombinant Proteins - immunology | Mannitol - immunology | CD8-Positive T-Lymphocytes - immunology | Neoplasms - pathology | Oleic Acids - immunology | Research | T cells | Tumor antigens | Biological Sciences
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 9/2006, Volume 103, Issue 39, pp. 14453 - 14458
Journal Article
PLOS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0150623
Journal Article
OncoImmunology, ISSN 2162-4011, 04/2016, Volume 5, Issue 4, p. e947175
A strategic challenge facing clinicians treating patients afflicted with non-small cell lung cancer (NSCLC) is the development of approaches that combine... 
targeted therapy | immune therapy | KRAS | NSCLC | MAGE-A | EGFR | ONCOLOGY | ANTIBODY | IMMUNOLOGY | IPILIMUMAB
Journal Article
OncoImmunology, ISSN 2162-4011, 12/2015, Volume 4, Issue 12, p. e946370
In a recent study, we have demonstrated that T helper type 1 (T H 1) cells specific for the tumor antigen NY-ESO-1 are amplified at ovarian tumor sites but are... 
NY-ESO-1 | CD4 | ovarian cancer | MHC class II tetramers | Treg | + | T cells | SURVIVAL | ONCOLOGY | IMMUNOLOGY | CD4(+) T cells
Journal Article
Journal Article
European Journal of Immunology, ISSN 0014-2980, 02/2015, Volume 45, Issue 2, pp. 474 - 479
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.